Epidemiology, Risk Factors, and Pathogenesis of Cholangiocarcinoma

Overview

Journal HPB (Oxford)

Publisher Elsevier

Specialty Gastroenterology

Date 2008 Sep 6

PMID 18773060

Citations 189

Authors

S A Khan

M B Toledano

S D Taylor-Robinson

Affiliations

Soon will be listed here.

Abstract

Cholangiocarcinoma (CCA) is a fatal cancer of the biliary epithelium, arising either within the liver (intrahepatic, ICC) or in the extrahepatic bile ducts (extrahepatic ECC). Globally, CCA is the second most common primary hepatic malignancy. Several recent epidemiological studies have shown that the incidence and mortality rates of ICC are increasing. This review of the literature on the international epidemiological rates of CCA, both intra- and extrahepatic, explores possible explanations for the trends found. The possible role of epidemiological artifact in the findings is discussed and the known risk factors for CCA are summarized. These include primary sclerosing cholangitis, liver fluke infestation, congenital fibropolycystic liver, bile duct adenomas, and biliary papillomatosis, hepatolithiasis, chemical carcinogens such as nitrosamines, Thorotrast, chronic viral hepatitis, cirrhosis, chronic non-alcoholic liver disease and obesity. Potential pathways involved in the molecular pathogenesis of CCA are also summarized.

Citing Articles

The role of artificial intelligence and image processing in the diagnosis, treatment, and prognosis of liver cancer: a narrative-review.

Dimopoulos P, Mulita A, Antzoulas A, Bodard S, Leivaditis V, Akrida I Prz Gastroenterol. 2025; 19(3):221-230.

PMID: 39802971 PMC: 11718495. DOI: 10.5114/pg.2024.143147.

HCG18 Promotes Cell Proliferation and Stemness in Cholangiocarcinoma via the miR-194-5p/KRT18/MAPK Signaling.

Tian G, Zuo L, Li J, Zheng X, Gao F Biochem Genet. 2025; .

PMID: 39776371 DOI: 10.1007/s10528-025-11020-7.

Spatial analysis of cholangiocarcinoma in Thailand from 2012 to 2021; a population-based cancer registries study.

Sahat O, Kamsa-Ard S, Suwannatrai A, Lim A, Kamsa-Ard S, Bilheem S PLoS One. 2024; 19(12):e0311035.

PMID: 39661606 PMC: 11633966. DOI: 10.1371/journal.pone.0311035.

Perihilar cholangiocarcinoma masquerading as intrahepatic cholestasis of pregnancy: a case report and review of the literature.

Xiao C, Cao C, Xiao X, Cheng Q Front Med (Lausanne). 2024; 11:1449865.

PMID: 39554499 PMC: 11566451. DOI: 10.3389/fmed.2024.1449865.

The Constellation of Risk Factors and Paraneoplastic Syndromes in Cholangiocarcinoma: Integrating the Endocrine Panel Amid Tumour-Related Biology (A Narrative Review).

Ciobica M, Sandulescu B, Chicea L, Iordache M, Groseanu M, Carsote M Biology (Basel). 2024; 13(9).

PMID: 39336089 PMC: 11429066. DOI: 10.3390/biology13090662.

References

Watanapa P, Watanapa W . Liver fluke-associated cholangiocarcinoma. Br J Surg. 2002; 89(8):962-70. DOI: 10.1046/j.1365-2168.2002.02143.x. View

Welzel T, Graubard B, El-Serag H, Shaib Y, Hsing A, Davila J . Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007; 5(10):1221-8. PMC: 2083573. DOI: 10.1016/j.cgh.2007.05.020. View

Khan S, Carmichael P, Taylor-Robinson S, Habib N, Thomas H . DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma. Gut. 2003; 52(4):586-91. PMC: 1773601. DOI: 10.1136/gut.52.4.586. View

Patel T . Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002; 2:10. PMC: 113759. DOI: 10.1186/1471-2407-2-10. View

Patel T . Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001; 33(6):1353-7. DOI: 10.1053/jhep.2001.25087. View

Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y . Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer. 2000; 88(11):2471-7. DOI: 10.1002/1097-0142(20000601)88:11<2471::aid-cncr7>3.0.co;2-t. View

Shin H, Lee C, Park H, Seol S, Chung J, Choi H . Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol. 1996; 25(5):933-40. DOI: 10.1093/ije/25.5.933. View

Sorensen H, Friis S, Olsen J, Thulstrup A, Mellemkjaer L, Linet M . Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology. 1998; 28(4):921-5. DOI: 10.1002/hep.510280404. View

Shaib Y, El-Serag H, Nooka A, Thomas M, Brown T, Patt Y . Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol. 2007; 102(5):1016-21. DOI: 10.1111/j.1572-0241.2007.01104.x. View

10.

Khan S, Thomas H, Davidson B, Taylor-Robinson S . Cholangiocarcinoma. Lancet. 2005; 366(9493):1303-14. DOI: 10.1016/S0140-6736(05)67530-7. View

11.

Sahani D, Prasad S, Tannabe K, Hahn P, Mueller P, Saini S . Thorotrast-induced cholangiocarcinoma: case report. Abdom Imaging. 2002; 28(1):72-4. DOI: 10.1007/s00261-001-0148-y. View

12.

Malhi H, Gores G . Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol. 2006; 45(6):856-67. PMC: 1686172. DOI: 10.1016/j.jhep.2006.09.001. View

13.

Hardell L, Bengtsson N, Jonsson U, Eriksson S, Larsson L . Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation. Br J Cancer. 1984; 50(3):389-97. PMC: 1976799. DOI: 10.1038/bjc.1984.188. View

14.

Welzel T, Mellemkjaer L, Gloria G, Sakoda L, Hsing A, El Ghormli L . Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer. 2006; 120(3):638-41. DOI: 10.1002/ijc.22283. View

15.

Shaib Y, El-Serag H, Davila J, Morgan R, McGlynn K . Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005; 128(3):620-6. DOI: 10.1053/j.gastro.2004.12.048. View

16.

Shaib Y, Davila J, McGlynn K, El-Serag H . Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol. 2004; 40(3):472-7. DOI: 10.1016/j.jhep.2003.11.030. View

17.

Okuda K, Nakanuma Y, Miyazaki M . Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol. 2002; 17(10):1049-55. DOI: 10.1046/j.1440-1746.2002.02781.x. View

18.

Chen M . Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol. 2000; 14(12):1144-9. DOI: 10.1046/j.1440-1746.1999.01983.x. View

19.

Welzel T, McGlynn K, Hsing A, OBrien T, Pfeiffer R . Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006; 98(12):873-5. DOI: 10.1093/jnci/djj234. View

20.

Berthiaume E, Wands J . The molecular pathogenesis of cholangiocarcinoma. Semin Liver Dis. 2004; 24(2):127-37. DOI: 10.1055/s-2004-828890. View